Our patented Rigenera® Technology enables the extraction and preparation of an autologous micrografting solution called AMT® Triad — composed of progenitor cells, human smart exosomes, and extracellular matrix from your own healthy tissue.
Autologous
Micrografting
Smart
Exosomes
No
Manipulation
No
Manipulation
The AMT® protocol is indicated for patients experiencing androgenetic alopecia at various stages, and can be combined with other treatments for enhanced outcomes.
Find a Certified ClinicTo empower medical professionals worldwide with the most advanced, evidence-based, and minimally invasive regenerative tools for hair restoration unlocking the human body's own innate healing intelligence to restore confidence and quality of life for patients affected by Androgenetic Alopecia.
To be the global reference in autologous regenerative medicine setting the scientific standard for safe, effective, and patient-centred hair restoration treatments, and expanding the AMT® platform into new therapeutic areas within regenerative medicine.
World-leading physicians and researchers who trust, use, and advocate for AMT®
technology in their clinical practice
Hair Treatment Doctor
Spain
Hair Treatment Doctor
Spain
Hair Transplant Surgeon
Spain
Trichologist and Hair Surgeon
Spain
Hair Transplant Surgeon
Spain
Dermatologist and tricologist
Spain
Medical Specialist in Aesthetic Medicine
Spain
Certified Spanish Trainer of Regenera Activa.
Spain
Dermatologist and Aesthetics Physician
Spain
Rigenera® EVO is a CE-marked medical device, compliant with EU Medical Device Regulation (MDR 2017/745).
Our quality management system for medical devices meets the highest international standards.
All clinical research follows ICH-GCP guidelines. Patient safety is our unconditional priority in every decision.